Cyclosporine 0.05% Ophthalmic Emulsion for Dry Eye in Korea: A Prospective, Multicenter, Open-Label, Surveillance Study
Open Access
- 1 January 2011
- journal article
- research article
- Published by Korean Ophthalmological Society in Korean Journal of Ophthalmology
- Vol. 25 (6), 369-374
- https://doi.org/10.3341/kjo.2011.25.6.369
Abstract
To assess the effectiveness and tolerability of cyclosporine ophthalmic emulsion (CsA) 0.05% in patients with moderate to severe dry eye disease in Korea. This was a prospective, multicenter, open-label, surveillance study of 392 Korean patients with moderate to severe dry eye disease who were treated with CsA 0.05% for three months. An assessment of effectiveness was performed at baseline, and after 1, 2, and 3 months. The primary effectiveness outcomes were changes in ocular symptoms and Schirmer score. The secondary effectiveness outcomes were a change in conjunctival staining, use of artificial tears, global evaluation of treatment, and patient satisfaction. The primary safety outcome was the incidence and nature of adverse events. A total of 362 patients completed the study. After three months, all ocular symptom scores were significantly reduced compared to the baseline values, while the Schirmer scores were significantly increased relative to baseline (p < 0.0001). After three months, there were significant reductions from baseline in conjunctival staining (p < 0.01) and use of artificial tears (p < 0.0001). According to clinicians' global evaluations, most patients (>50%) experienced at least a 25% to 50% improvement in symptoms from baseline at each follow-up visit. The majority of patients (72.0%) were satisfied with the treatment results, and 57.2% reported having no or mild symptoms after treatment. The most common adverse events were ocular pain (11.0%). Our findings indicate that CsA 0.05% is an effective and tolerable treatment for dry eye disease in Korean clinical practice.Keywords
This publication has 30 references indexed in Scilit:
- Efficacy of different dry eye treatments with artificial tears or ocular lubricants: a systematic reviewOphthalmic and Physiological Optics, 2009
- Cinical Effect of Restasis® Eye Drops in Mild Dry Eye SyndromeJournal of the Korean Ophthalmological Society, 2009
- Prevalence of dry eye among adult Chinese in the Beijing Eye StudyEye, 2008
- Clinical Effect of Cyclosporine 0.05% Eye Drops in Dry Eye Syndrome PatientsJournal of the Korean Ophthalmological Society, 2008
- Impact of Dry Eye Syndrome on Vision-Related Quality of LifeAmerican Journal of Ophthalmology, 2007
- Short Term Effects of Topical Cyclosporine and Viscoelastic on the Ocular Surfaces in Patients with Dry EyeKorean Journal of Ophthalmology, 2007
- Self-reported compliance with topical cyclosporine emulsion 0.05% and onset of the effects of increased tear production as assessed through patient surveysClinical Therapeutics, 2006
- Association between Symptoms and Signs of Dry Eye among an Elderly Chinese Population in Taiwan: The Shihpai Eye StudyInvestigative Ophthalmology & Visual Science, 2005
- The Economic Burden of Dry EyeCornea, 2004
- The epidemiology of dry eye in Melbourne, Australia, Historical imageOphthalmology, 1998